Hasbro (HAS) Declares $0.68 Quarterly Dividend; 2.7% Yield

Go back to Hasbro (HAS) Declares $0.68 Quarterly Dividend; 2.7% Yield

Hasbro (HAS) PT Raised to $128 at DA Davidson

July 27, 2021 8:39 AM EDT

DA Davidson analyst Linda Bolton Weiser raised the price target on Hasbro (NASDAQ: HAS) to $128.00 (from $120.00) while maintaining a Buy rating.

The analyst commented, "HAS closed +12% on a big 2Q21 upside surprise, with sales +54% and +9% vs. 2Q19. HAS still expects double-digit sales... More

Hasbro (HAS) PT Raised to $116 at Stifel

July 27, 2021 8:19 AM EDT

Stifel analyst Drew Crum raised the price target on Hasbro (NASDAQ: HAS) to $116.00 (from $114.00) while maintaining a Buy rating.... More

Hasbro (HAS) PT Raised to $120 at Jefferies

July 27, 2021 7:48 AM EDT

Jefferies analyst Stephanie Wissink raised the price target on Hasbro (NASDAQ: HAS) to $120.00 (from $115.00) while maintaining a Buy rating.

The analyst commented, "We see Q2 as a hallmark quarter, validating staying the course despite peripheral disruptions to the business. Sales & EBITDA handily... More

Hasbro (HAS) PT Raised to $105 at Truist Securities

July 27, 2021 7:16 AM EDT

Truist Securities raised its price target on Hasbro (NASDAQ: HAS) to $105.00 (from $100.00) while maintaining a Hold rating.... More

Hasbro (HAS) PT Raised to $110 at BofA Securities

July 27, 2021 5:01 AM EDT

BofA Securities analyst Devin Brisco raised the price target on Hasbro (NASDAQ: HAS) to $110.00 (from $106.00) while maintaining a Neutral rating.... More

Increasing unusual put option volume: TRIT IBKR MLCO MGM HAS

July 26, 2021 10:16 AM EDT

Increasing unusual put option volume: TRIT IBKR MLCO MGM HAS

... More

Pre-Open Stock Movers 07/26: (TYME) (MSTR) (FLOW) Higher; (ATIP) (ITRM) (TNXP) Lower (more...)

July 26, 2021 9:29 AM EDT

Pre-Open Stock Movers:

Tyme Technologies, Inc. (NASDAQ: TYME) 54.6% HIGHER; announced that it has received notification that the United States Patent and Trademark Office has granted additional patent claims related to the Companys metabolomic technology platform. The patent, U.S. Patent No. 11,058,638, involves a targeted delivery of therapeutics to cancer cells.

ATI Physical Therapy (NYSE: ATIP) 41.3% LOWER; reported Q2 revenue of $164 million versus the consensus estimate of $175.37 million. For full year 2021, ATI is now... More